Navigation Links
DOs and DON’Ts of Study Start-Up: Best Practices to Improve Efficiency and Meet/Exceed Timelines, New Life Science Webinar Hosted by Xtalks

Toronto, Canada (PRWEB) July 11, 2013

Efficient and effective study start-up is crucial to the success of every study. From country and site selection to resource oversight, there are challenges embedded in every investigation that can impact study start and timely delivery.

In order to address these challenges and set the path for success, several questions should be considered:

  •     How do you select countries and sites that will improve your chances of finding and retaining the right patients for your study?
  •     Can you cost-effectively implement a proactive patient strategy, and avoid the need for rescue programs?
  •     How can you leverage data and planning techniques to minimize management oversight while optimizing efficiencies by matching studies, sites, and patients impacting patient health?

In this webinar, experts from Quintiles will discuss best practices for applying quantitative and qualitative information to develop study strategies, from feasibility through patient recruitment. The speakers will highlight how an empowered delivery team can enhance efficiency, minimize the need for extensive oversight, and deliver greater overall accountability for meeting your study goals.

Through case examples, we will show how the appropriate tools and insight from data and strategies are applied in a real-world setting to deliver tangible benefits to clinical development stakeholders.

To learn more about the event, visit:

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year, thousands of industry practitioners turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit

Karen Lim (416) 977-6555 ext 227

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Study Scavenger and Announce Alliance Utilizing Smart Phone Capabilities to Bring Clinical Trials to Motivated Subjects
2. New Approaches in Immunogenicity Assessment Using the New SQiDlite™ System: Case Study Analysis, New Life Science Webinar Hosted by Xtalks
3. New Study Reveals that PEEK Polymer Spinal Cage Is Superior to Titanium in Surgical Treatment of Multilevel Cervical Spondylotic Myelopathy
4. Americord Applauds Study on Stem Cell Therapy for Congenital Heart Defects
5. Study Data Tabulation Model in Real Time, New Webinar Hosted by Xtalks
6. RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants
7. Lilly and Incyte Announce Baricitinib Efficacy and Safety Data from the Open-Label, Long-Term Extension of the Phase 2b JADA Study in Patients with Rheumatoid Arthritis
8. Are Root Canals Headed for Obscurity? Stem Cell Study Indicates Maybe So
9. Adult Acne Treatment Explains a New Upcoming Study that may Change the Acne Treatment Industry
10. Ambit Announces Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the Annual Meeting of the American Society of Clinical Oncology
11. Endpoint Based Protocol Development: A Central Laboratory Perspective + Microbiology Case Study, New Life Science Webinar Hosted by Xtalks
Post Your Comments:
(Date:11/24/2015)... SAN DIEGO , Nov. 24, 2015 Halozyme Therapeutics, ... Jaffray Healthcare Conference in New York on ... Dr. Helen Torley , president and CEO, will provide a ... New York at 1:00 p.m. ET/10:00 a.m. ... communication and investor relations, will provide a corporate overview. --> ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris ... of IIROC on behalf of the Toronto Stock Exchange, ... release there are no corporate developments that would cause ... --> --> About Aeterna ... . --> Aeterna Zentaris is a ...
(Date:11/24/2015)... IN (PRWEB) , ... November 24, 2015 , ... The ... newest Special Interest Group (SIG), MultiGP, also known as Multirotor Grand Prix, to represent ... the last few years. Many AMA members have embraced this type of racing and ...
(Date:11/24/2015)... QUEBEC CITY , Nov. 24, 2015 /PRNewswire/ ... (the "Company") announced today that the remaining 11,000 ... Common Share Purchase Warrants (the "Series B Warrants") ... agreement were exercised on November 23, 2015, which ... Common Shares.  After giving effect to the issuance ...
Breaking Biology Technology:
(Date:11/19/2015)... NEW YORK , Nov. 19, 2015  Although ... the market is dominated by a few companies, according ... Qiagen. These companies own 51% of the market share of ... report, The World Market for Molecular Diagnostic ... "The market is still controlled by one ...
(Date:11/17/2015)... 2015  Vigilant Solutions announces today that Mr. ... Directors. --> --> ... the partnership at TPG Capital, one of the largest ... Billion in revenue.  He founded and led TPG,s Operating ... companies, from 1997 to 2013.  In his first role, ...
(Date:11/12/2015)... 11, 2015   Growing need for low-cost, ... has been paving the way for use of ... discrete analytes in clinical, agricultural, environmental, food and ... used in medical applications, however, their adoption is ... to continuous emphasis on improving product quality and ...
Breaking Biology News(10 mins):